-+ 0.00%
-+ 0.00%
-+ 0.00%

*AbbVie Will Acquire Capstan, Including CPTX2309, a Potential First-In-Class in Vivo tLNP anti-CD19 CAR-T Therapy Candidate >ABBV

Dow Jones·06/30/2025 12:33:00

Please log in to view news